indazoles has been researched along with Adenocystic Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonescu, CR; Baxi, SS; Chandramohan, R; Cullen, GD; Dogan, S; Dunn, L; Fury, MG; Haque, S; Ho, AL; Katabi, N; Morris, LG; Ni, A; Pfister, DG; Sherman, EJ; Sima, CS | 1 |
1 trial(s) available for indazoles and Adenocystic Carcinoma
Article | Year |
---|---|
A phase II study of axitinib (AG-013736) in patients with incurable adenoid cystic carcinoma.
Topics: Adult; Aged; Axitinib; Carcinoma, Adenoid Cystic; Chromosomes, Human, Pair 4; Disease-Free Survival; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Female; High-Throughput Nucleotide Sequencing; Humans; Imidazoles; Indazoles; Male; Middle Aged; NFI Transcription Factors; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-myb | 2016 |